JP2023513797A5 - - Google Patents
Info
- Publication number
- JP2023513797A5 JP2023513797A5 JP2022549152A JP2022549152A JP2023513797A5 JP 2023513797 A5 JP2023513797 A5 JP 2023513797A5 JP 2022549152 A JP2022549152 A JP 2022549152A JP 2022549152 A JP2022549152 A JP 2022549152A JP 2023513797 A5 JP2023513797 A5 JP 2023513797A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977041P | 2020-02-14 | 2020-02-14 | |
| US62/977,041 | 2020-02-14 | ||
| PCT/US2021/018044 WO2021163633A1 (en) | 2020-02-14 | 2021-02-12 | Mono and combination therapies with ulk1/2 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513797A JP2023513797A (ja) | 2023-04-03 |
| JP2023513797A5 true JP2023513797A5 (https=) | 2024-02-20 |
| JPWO2021163633A5 JPWO2021163633A5 (https=) | 2024-02-20 |
Family
ID=77292775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549152A Pending JP2023513797A (ja) | 2020-02-14 | 2021-02-12 | Ｕｌｋ１／２阻害剤による単剤療法および併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230130766A1 (https=) |
| EP (1) | EP4103186A4 (https=) |
| JP (1) | JP2023513797A (https=) |
| KR (1) | KR20220154094A (https=) |
| CN (1) | CN115484956A (https=) |
| AU (1) | AU2021218740A1 (https=) |
| WO (1) | WO2021163633A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220153582A (ko) | 2020-02-14 | 2022-11-18 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 마크로시클릭 ulk1/2 억제제 |
| WO2022072668A1 (en) * | 2020-09-30 | 2022-04-07 | Salk Institute For Biological Studies | Patient selection biomarkers for treatment with ulk inhibitors |
| WO2024140401A1 (zh) * | 2022-12-30 | 2024-07-04 | 捷思英达控股有限公司 | 作为激酶抑制剂的杂环化合物以及包括其的组合物 |
| WO2025045182A1 (zh) * | 2023-09-01 | 2025-03-06 | 深圳众格生物科技有限公司 | Ulk1抑制剂及其制备方法和用途 |
| WO2025166124A1 (en) * | 2024-02-02 | 2025-08-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
| WO2025166180A1 (en) * | 2024-02-02 | 2025-08-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
| WO2025166161A1 (en) * | 2024-02-02 | 2025-08-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06013165A (es) * | 2004-05-14 | 2007-02-13 | Pfizer Prod Inc | Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal. |
| WO2006037117A1 (en) * | 2004-09-27 | 2006-04-06 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| DK3185868T3 (da) * | 2014-08-25 | 2022-05-23 | Salk Inst For Biological Studi | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme |
| RS62017B1 (sr) * | 2014-09-17 | 2021-07-30 | Celgene Car Llc | Mk2 inhibitori i njihova upotreba |
-
2021
- 2021-02-12 JP JP2022549152A patent/JP2023513797A/ja active Pending
- 2021-02-12 KR KR1020227028939A patent/KR20220154094A/ko active Pending
- 2021-02-12 US US17/799,641 patent/US20230130766A1/en active Pending
- 2021-02-12 WO PCT/US2021/018044 patent/WO2021163633A1/en not_active Ceased
- 2021-02-12 CN CN202180027793.4A patent/CN115484956A/zh active Pending
- 2021-02-12 AU AU2021218740A patent/AU2021218740A1/en active Pending
- 2021-02-12 EP EP21754343.8A patent/EP4103186A4/en not_active Withdrawn